Date published: 2026-5-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

ATF-6 Inhibitors

Chemical inhibitors of ATF-6 can exert their inhibitory effects through various mechanisms that disrupt the protein's activation and function within the cellular environment. AEBSF, a serine protease inhibitor, prevents the proteolytic activation of ATF-6, which is a necessary step for its function in response to endoplasmic reticulum (ER) stress. Similarly, E-64, by irreversibly inhibiting cysteine proteases, disrupts the proteolytic processing of ATF-6, an event crucial for its activation. ALLN, or Calpain Inhibitor I, targets calpains and the proteasomal degradation pathways, both of which are involved in the cleavage and regulation of ATF-6, leading to its inhibition. MG-132 further impedes ATF-6 by inhibiting the proteasome, which is responsible for degrading misfolded proteins and could also degrade ATF-6's cytoplasmic domain, reducing its transcriptional activity.

Kifunensine and Tunicamycin disrupt glycosylation processes; since ATF-6 requires proper glycosylation for its function, interference from these chemicals results in its inhibition. Brefeldin A disrupts ER-to-Golgi trafficking, a pathway essential for ATF-6 to undergo activation. This disruption prevents ATF-6 from reaching the Golgi where it is processed into its active form. Thapsigargin, by inhibiting SERCA, induces ER stress, which can lead to ATF-6 degradation before it becomes functionally active. Salubrinal and Guanabenz extend the phosphorylation state of eIF2α, a modification that is required for ATF-6 activation during ER stress; therefore, their action results in the inhibition of ATF-6. Sephin1 also targets the phosphorylation of eIF2α, ensuring that ATF-6 remains inactive by preventing the attenuation of stress signals necessary for its activation. Lastly, ISRIB inhibits the activation of ATF-6 by reversing the effects of eIF2α phosphorylation, a critical step for ATF-6 function, thereby maintaining ATF-6 in an inactive state. Each of these chemicals acts on specific pathways or cellular processes that are intimately connected to the proper functioning of ATF-6, resulting in its inhibition.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

AEBSF hydrochloride

30827-99-7sc-202041
sc-202041A
sc-202041B
sc-202041C
sc-202041D
sc-202041E
50 mg
100 mg
5 g
10 g
25 g
100 g
$65.00
$122.00
$428.00
$851.00
$1873.00
$4994.00
33
(1)

AEBSF inhibits serine proteases, which are necessary for ATF-6 activation by proteolytic cleavage during the unfolded protein response. By inhibiting these proteases, AEBSF prevents the activation of ATF-6.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

E-64 is an irreversible cysteine protease inhibitor; by inhibiting these proteases, it can prevent the cleavage and activation of ATF-6, which requires processing by cysteine proteases.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG-132 is a proteasome inhibitor that can prevent the degradation of ATF-6's cytoplasmic domain, impeding its transcriptional activity.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$135.00
$540.00
$1025.00
$6248.00
25
(2)

Kifunensine is a mannosidase inhibitor, which affects the glycosylation of proteins. Proper glycosylation is necessary for ATF-6 to function properly, thus inhibition can lead to ATF-6 functional inhibition.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Brefeldin A disrupts ER-to-Golgi trafficking, which is essential for ATF-6 to reach locations where it gets activated through proteolytic cleavage. This results in the functional inhibition of ATF-6.

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Tunicamycin inhibits N-linked glycosylation, which is critical for ATF-6 to maintain its proper function and stability, hence its inhibition can functionally inhibit ATF-6.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin inhibits the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to ER stress; sustained ER stress can lead to ATF-6 degradation and therefore functional inhibition.

Salubrinal

405060-95-9sc-202332
sc-202332A
1 mg
5 mg
$34.00
$104.00
87
(2)

Salubrinal selectively inhibits dephosphorylation of eIF2α. Phosphorylated eIF2α is implicated in ATF-6 activation, thus salubrinal can prevent ATF-6 from being functionally active.

Guanabenz acetate

23256-50-0sc-203590
sc-203590A
sc-203590B
sc-203590C
sc-203590D
100 mg
500 mg
1 g
10 g
25 g
$102.00
$468.00
$832.00
$4162.00
$7283.00
2
(2)

Guanabenz can selectively inhibit the dephosphorylation of eIF2α similar to Salubrinal. This will inhibit ATF-6 activation by preventing its translocation to the Golgi.

Sephin1

13098-73-2sc-507502
5 mg
$578.00
(0)

Sephin1 prolongs the eIF2α phosphorylation response. Persistently phosphorylated eIF2α can lead to inhibition of ATF-6 activation due to failure to induce proper UPR signaling.